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Abstract
Antimicrobial resistance (AMR) surveillance systems are generally not specifically designed
to detect emerging resistances and usually focus primarily on resistance to individual drugs.
Evaluating the diversity of resistance, using ecological metrics, allows the assessment of
sampling protocols with regard to the detection of rare phenotypes, comprising combina-
tions of resistances. Surveillance data of phenotypic AMR of Canadian poultry Salmonella
Heidelberg and swine Salmonella Typhimurium var. 5- were used to contrast active (repre-
sentative isolates derived from healthy animals) and passive (diagnostic isolates) surveil-
lance and assess their suitability for detecting emerging resistance patterns. Although in
both datasets the prevalences of resistance to individual antimicrobials were not signifi-
cantly different between the two surveillance systems, analysis of the diversity of entire
resistance phenotypes demonstrated that passive surveillance of diagnostic isolates
detected more unique phenotypes. Whilst the most appropriate surveillance method will
depend on the relevant objectives, under the conditions of this study, passive surveillance
of diagnostic isolates was more effective for the detection of rare and therefore potentially
emerging resistance phenotypes.
Introduction
Bacterial infections resistant to antimicrobial drugs pose a great threat to animal and human
health [1]. Although many antimicrobials and antimicrobial resistance are natural phenomena
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and have existed for millennia [2], the widespread use of antimicrobials in animals and
humans, and to a lesser extent in plants, has resulted in global selection pressures that have
greatly escalated the evolution and spread of resistance [3]. Early detection of antimicrobial
resistance (AMR) in bacterial species is critical if we are to understand the drivers of this prob-
lem, and moreover, identify and implement candidate mitigation strategies [4–7]. Govern-
ments and intergovernmental organisations now recognise the importance of this activity,
identifying surveillance for emerging resistance as a priority for infection control [8,9].
Surveillance can be defined in several ways: For the purposes of this analysis and although it
may in practice be something different, passive surveillance is defined as the ongoing monitor-
ing of infections, based on diagnostic isolates submitted from clinically diseased individuals or
groups; active surveillance is defined as the planned collection of targeted and representative
samples, often and this case in surveillance of AMR in the foodchain, from putatively healthy
animals. Each approach has different characteristics that affect the nature and strength of infer-
ence that can be drawn from the generated data [10,11]. Passive surveillance is usually less
costly and more widely used, but may not represent the characteristics of the general host and
microbial populations. Biases may also arise through variation in clinician submission behav-
iours, outbreak episodes, the submission of multiple isolates per individual, and different labo-
ratory methods [12–14]. Furthermore, useful denominator information, such as the number of
samples tested but found negative, is frequently not provided. Active surveillance, on the other
hand, better reflects the characteristics of the general population, but is usually more costly. In
surveillance of AMR in the foodchain, active surveillance of healthy animals, on farm or at
slaughter, and retail meat is often used to generate representative estimates for monitoring the
trends over time of resistances entering and moving through the foodchain. Detection of the
emergence of resistance, despite its importance, is often a secondary objective and may not
have been specifically accounted for in programme design. However, in surveillance of AMR in
the foodchain, early detection of rare and emerging resistance phenotypes is a critical issue,
and identifying which surveillance approach is more efficient equally important in AMR sur-
veillance planning.
Surveillance of AMR has been reviewed previously [4,11–13,15–21], but there has been lim-
ited direct comparison of the different systems, particularly using data generated by the same
laboratory using the same microbiological techniques. A common approach to comparing data
obtained by the two systems is to compare the prevalence of resistance to individual antimicro-
bials rather than the phenotypes of combined resistances associated with each isolate. Here,
using exemplar data from two host species collected by the Canadian Integrated Program for
Antimicrobial Resistance Surveillance (CIPARS), we determine and compare the prevalence of
resistance to individual antimicrobials of Salmonella isolates from active surveillance of healthy
animals at slaughter or on farm, and passive surveillance utilising veterinary clinical diagnostic
isolates. We contrast the results with an analysis of the diversity of resistance phenotypes
observed in isolates from each system, with a focus on assessing the suitability of each method
for the identification of new or re-emerging resistances, as determined by the detection of rare
phenotypes.
Materials and Methods
Data
CIPARS is a national surveillance programme which monitors trends in antimicrobial use and
AMR in selected bacteria from animal, human and food sources across Canada [22], including
components of both active and passive surveillance.
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Salmonella Typhimurium var. 5- swine isolates (swine), and Salmonella Heidelberg poultry
isolates (poultry), were selected as case studies for these analyses. In this analysis, all poultry
isolates were from chickens; those from other species, i.e., turkeys and other poultry species,
were excluded. Passive surveillance data were generated from diagnostic samples submitted by
producers or veterinarians to provincial and private animal health laboratories and then to the
Salmonella Typing Laboratory at the Laboratory for Foodborne Zoonoses (LFZ), Public Health
Agency of Canada (PHAC), Guelph, Ontario for serotyping and/or phage typing. In general,
these samples are primarily from diseased animals but may also have been collected from ani-
mal feed, the environment of a diseased animal, or non-diseased animals from the same herd
or flock; for the purposes of this analysis, isolates obtained from feed, environmental samples
or from food products were excluded. Active surveillance data were derived from samples
obtained by CIPARS through their on-farm and abattoir components; 25 swine isolates derived
from a Canadian food safety surveillance program (FoodNet Canada, formerly C-EnterNet)
with an on-farm component similar to that of CIPARS were also included. The CIPARS active
surveillance is designed to ensure a random and representative sample of isolates across the
year, proportional to the annual slaughter volume (abattoir component) and number of
grower-finisher sites (swine on-farm component); further details on the sampling framework
are available in the CIPARS annual reports [22]. Isolates included in this analysis were S.
Typhimurium var. 5- isolates from swine and S. Heidelberg isolates from chickens, collected
between 2002–2007. Antimicrobial susceptibility testing was performed using the Sensititre1
automated microdilution method, and isolates were classified as resistant or non-resistant to
each antimicrobial according to breakpoints from the Clinical and Laboratory Standards Insti-
tute (CLSI) [23]. Where no CLSI breakpoints were available, minimum inhibitory concentra-
tion distributions were used to define epidemiological breakpoints [22]. Full information on 15
antimicrobials was available. Susceptibility testing was conducted by the CIPARS AMR Labo-
ratory, LFZ, PHAC, Guelph, Ontario, Canada. The resistance profile (phenotype) for each iso-
late was compiled, detailing the antimicrobials to which resistance was demonstrated.
Prevalence analysis
The prevalence of resistance to each individual antimicrobial and the Wilson score-test-based
95% confidence intervals were calculated [24–26]. To assess whether or not the prevalence of
resistance to individual antimicrobials was significantly different between active and passive
surveillance isolates, chi-square tests were applied to the numbers of isolates that were suscepti-
ble and resistant to each antimicrobial detected by each surveillance system; in cases of low
isolate numbers in any cell in the 2x2 table, a Fisher’s Exact test was employed [26]. The signifi-
cant p-value cut-off was set at 0.0033, Bonferroni-corrected from 0.05 divided to account for
the 15 antimicrobials tested.
The percentage resistance was computed to express the average resistance to the 15 antimi-
crobials of interest among the active and passive surveillance isolates:
Percentage Resistance ¼ Total # Resistances
Total # Antimicrobials Total # Isolates
where ‘Total # Resistances’ is the summation of all instances of resistance for a given set of iso-
lates to any tested antimicrobial, ‘Total # Antimicrobials’ is the number of antimicrobials
against which resistance was assessed, and ‘Total # Isolates’ is the total number of isolates in
the given set of isolates. This metric was calculated to compare with previously published
results [27,28].
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The prevalences of multidrug resistance (MDR), defined as resistance to three or more dif-
ferent antimicrobial classes, in the isolates collected by active and passive surveillance were cal-
culated and compared. The antimicrobial classes examined in this study were quinolones
(nalidixic acid and ciprofloxacin), aminoglycosides (kanamycin, gentamicin, amikacin,
streptomycin), penicillins (ampicillin, amoxicillin-clavulanic acid), cephalosporins (ceftiofur,
ceftriaxone, cefoxitin), tetracyclines (tetracycline), folate pathway inhibitors (sulphonamides,
trimethoprim-sulphamethoxazole), and phenicols (chloramphenicol). A similar analysis,
where the penicillins and cephalosporins were combined into a single, beta-lactam, drug class,
was also performed. Each isolate was classified as either MDR or not MDR, and the numbers of
MDR isolates compared between active and passive surveillance using Fisher’s Exact tests.
Diversity analysis
Two methods were employed to evaluate the diversity of resistance in each dataset, using the
AMR phenotype. First, to investigate whether or not the two surveillance methods sampled
from a common population of resistance phenotypes, a statistical resampling approach was
used, as described in Mather et al. [29]. Briefly, the numbers of phenotypes detected by active
and passive surveillance were tabulated. Then, for each of 10,000 iterations, the surveillance
method by which each of the isolates in the dataset was sampled was randomly reassigned to
another isolate, and the new number of phenotypes in each category (active and passive) tabu-
lated, generating a distribution of results consistent with an origin from a common population.
For each dataset separately, the observed numbers of phenotypes obtained by each method
were compared to the resampled distributions of the numbers of phenotypes expected, and
were considered to be significantly different from that expected if they fell within the first or
last 2.5th percentiles of the resampled distributions (p<0.05, two-tailed test). The null hypothe-
sis that resistance phenotypes in isolates obtained by active and passive surveillance derived
from a single community of resistance phenotypes was rejected if the observed number of phe-
notypes was significantly different from that expected for either the active or passive surveil-
lance isolates.
The second method involved calculating ecological measures of diversity for the active and
passive surveillance data for each dataset (swine and poultry), as described in Mather et al.
[29], using a family of diversity measures related to Rényi’s entropy measures [30], that differ-
entially weight the importance of species richness (the number of total resistance phenotypes)
and species abundance (the number of each individual phenotype) (Eq 1). The single parame-
ter q (previously α in [29]) determines the extent to which rare resistance phenotypes contrib-
ute towards overall diversity.
Dqðp1    psÞ ¼
Xs
i¼1
pqi
" # 1
1 q
q 6¼ 1
Ys
i¼1
ppii q ¼ 1
ð1Þ
8>>><
>>>:
where p1. . .ps are the s non-zero relative phenotype abundances
Four specific measures of diversity were examined, Species richness (SR), Shannon entropy
(SE), Simpson diversity (SD), and Berger-Parker (BP), as well as across the whole range of the
parameter q. When q = 0 (SR), rare and common phenotypes contribute equally; at q =1
(BP), rare phenotypes do not contribute to the measure at all, and it is the proportion of isolates
that have the most common phenotype that determines the measure. For SE and SD, there is a
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balance between the contribution of species richness and abundance to the diversity measure.
In order to account for differences in sample size, the larger sample of isolates was repeatedly
subsampled to the size of the smaller sample of isolates, and diversity measures calculated for
the subsamples. For the purposes of our analyses, we were most interested in the results when q
approached zero, as it is this end of the diversity measure spectrum that relates to new or emer-
gent (rare) phenotypes. The results for all diversity measures for active and passive surveillance
isolates were plotted for each dataset.
Results
There were 463 swine isolates, 51% collected by passive and 49% by active surveillance (S1
Table). There were 41 phenotypes obtained by passive surveillance (17 of which were unique to
passive surveillance isolates) and 36 by active surveillance (12 of which were unique to active
surveillance isolates); overall, 53 phenotypes (24 common to both surveillance methods) were
observed in the swine data. Of the 330 poultry isolates, 25% were collected by passive and 75%
by active surveillance (S2 Table). There were 14 phenotypes obtained by passive surveillance (6
of which were unique to passive surveillance isolates), 14 by active surveillance (6 of which
were unique to active surveillance isolates), with 20 phenotypes overall (8 common to both sur-
veillance methods) observed in the poultry data.
Prevalence analysis
The prevalences of resistance to each antimicrobial for passive and active surveillance in the
swine and poultry data are presented in Tables 1 and 2. For each antimicrobial, the prevalences
of resistance were not significantly different between active and passive surveillance for both
the swine and poultry data using the Bonferroni-corrected p-value of 0.0033. The percentages
Table 1. Number of resistant isolates (# R) and prevalences of resistance to each antimicrobial with 95% confidence intervals (CI) examined for
the isolates obtained by passive and active surveillance of swine S. Typhimurium var. 5-. No significant differences were detected by chi-square or
Fisher’s Exact tests.
Active surveillance Passive surveillance
Antimicrobial* # R isolates (total 227) Prevalence as % (95% CI) # R isolates (total 236) Prevalence as % (95% CI)
AMC 4 1.8 (0.7–4.4) 5 2.1 (0.9–4.9)
AP 149 65.6 (59.2–71.5) 180 76.3 (70.5–81.3)
AK 0 0.0 (0.0–1.7) 0 0.0 (0.0–1.6)
GM 4 1.8 (0.7–4.4) 9 3.8 (2.0–7.1)
KA 67 29.5 (24.0–35.8) 77 32.6 (27.0–38.8)
ST 156 68.7 (62.4–74.4) 172 72.9 (66.9–78.2)
CF 0 0.0 (0.0–1.7) 1 0.4 (0.0–2.4)
CX 0 0.0 (0.0–1.7) 0 0.0 (0.0–1.6)
CN 0 0.0 (0.0–1.7) 1 0.4 (0.0–2.4)
NAL 0 0.0 (0.0–1.7) 0 0.0 (0.0–1.6)
CP 0 0.0 (0.0–1.7) 0 0.0 (0.0–1.6)
SX 164 72.2 (66.1–77.7) 198 83.9 (78.7–88.0)
SXT 12 5.3 (3.1–9.0) 29 12.3 (8.7–17.1)
TE 186 81.9 (76.4–86.4) 200 84.7 (79.6–88.8)
CL 121 53.3 (46.8–59.7) 138 58.5 (52.1–64.6)
* AMC: amoxicillin-clavulanic acid; AP: ampicillin; AK: amikacin; GM: gentamicin; KA: kanamycin; ST: streptomycin; CF: ceftiofur; CX: ceftriaxone; CN:
cefoxitin; NAL: nalidixic acid; CP: ciprofloxacin; SX: sulphonamides; SXT: trimethoprim-sulphamethoxazole; TE: tetracycline; CL: chloramphenicol
doi:10.1371/journal.pone.0158515.t001
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of resistance were similar for the passive and active surveillance isolates for both the swine and
poultry data, and are presented in Table 3. In the swine data, 81% (190/236) of the passive sur-
veillance isolates were MDR and 69% (156/227) of the active surveillance isolates were MDR.
In the poultry data, 10% (8/84) of the passive surveillance isolates were MDR and 2% (4/246)
of the active surveillance isolates were MDR. The prevalence of MDR was higher in passive sur-
veillance isolates for both the swine (p = 0.004) and poultry (p = 0.003) data. Similar results
were obtained when the penicillins and cephalosporins were combined into a single beta-lac-
tam drug class.
Diversity analysis
In the poultry data, the number of phenotypes obtained by passive surveillance was signifi-
cantly higher than expected (in the 98th percentile), and the number of phenotypes obtained by
active surveillance significantly lower than expected (in the 2nd percentile). In the swine data,
the observed numbers of phenotypes obtained by both passive and active surveillance were
Table 2. Number of resistant isolates (# R) and prevalences of resistance to each antimicrobial with 95% confidence intervals (CI) examined for
the isolates obtained by passive and active surveillance of poultry S. Heidelberg. No significant differences were detected by chi-square or Fisher’s
Exact tests.
Active surveillance Passive surveillance
Antimicrobial* # R isolates (total 246) Prevalence in % (95% CI) # R isolates (total 84) Prevalence in % (95% CI)
AMC 55 22.4 (17.6–28.0) 13 15.5 (9.3–24.7)
AP 99 40.2 (34.3–46.5) 27 32.1 (23.1–42.7)
AK 0 0.0 (0.0–1.5) 0 0.0 (0.0–4.4)
GM 11 4.5 (2.5–7.8) 1 1.2 (0.1–6.4)
KA 4 1.6 (0.6–4.1) 2 2.4 (0.7–8.3)
ST 22 8.9 (6.0–13.2) 13 15.5 (9.3–24.7)
CF 55 22.4 (17.6–28.0) 13 15.5 (9.3–24.7)
CX 0 0.0 (0.0–1.5) 0 0.0 (0.0–4.4)
CN 55 22.4 (17.6–28.0) 13 15.5 (9.3–24.7)
NAL 1 0.4 (0.0–2.3) 0 0.0 (0.0–4.4)
CP 0 0.0 (0.0–1.5) 0 0.0 (0.0–4.4)
SX 13 5.3 (3.1–8.8) 6 7.1 (3.3–14.7)
SXT 1 0.4 (0.0–2.3) 1 1.2 (0.1–6.4)
TE 6 2.4 (1.1–5.2) 5 6.0 (2.6–13.2)
CL 0 0.0 (0.0–1.5) 1 1.2 (0.1–6.4)
* AMC: amoxicillin-clavulanic acid; AP: ampicillin; AK: amikacin; GM: gentamicin; KA: kanamycin; ST: streptomycin; CF: ceftiofur; CX: ceftriaxone; CN:
cefoxitin; NAL: nalidixic acid; CP: ciprofloxacin; SX: sulphonamides; SXT: trimethoprim-sulphamethoxazole; TE: tetracycline; CL: chloramphenicol
doi:10.1371/journal.pone.0158515.t002
Table 3. Percentages of resistance. Percentages of resistance (% R) for isolates obtained by passive and active surveillance of swine S. Typhimurium
var. 5- and poultry S. Heidelberg, including the % R of passive and active surveillance isolates found by Poppe et al. [27] and Johnson et al. [28] for
comparison.
%R Active Surveillance % R Passive Surveillance
Swine S. Typhimurium var. 5- 25.3 28.5
Poultry S. Heidelberg 8.7 7.5
Poppe et al. [27] 6.0 11.8
Johnson et al. [28] Mean of 11.8% R for active surv. and passive surv. isolates combined, ranging between 0.0–30.9
depending on serovar
doi:10.1371/journal.pone.0158515.t003
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within the distribution of expected results (in the 52nd and 5th percentiles of expected results,
respectively). Although there is no statistical support for the hypothesis that the phenotypes
were sampled from different populations in the swine data, similar trends to those seen in the
poultry data were observed, in that the number of phenotypes observed by active surveillance
was towards the lower end of that expected.
For several diversity measures in both the swine and poultry data, the diversities of pheno-
types obtained by active and passive surveillance were indistinguishable, including those where
species richness and abundance both contribute (SE and SD); where rare phenotypes do not
contribute at all (BP), the active surveillance phenotypes were slightly more diverse. However,
at low values of q, where rare phenotypes increasingly contribute to the overall diversity mea-
sure, passive surveillance phenotypes were more diverse than active surveillance phenotypes
(Figs 1 and 2).
Discussion
Ongoing surveillance of antimicrobial resistance in bacterial pathogens is central to developing
an understanding of the scope of the problem, to monitoring trends, and to evaluating impacts
of any intervention strategies. The comparison of active and passive surveillance systems is also
important as is the population they are drawing from, as there are differences in terms of the
economic and effort costs, as well as the potential biases implicit in each. Sometimes, the two
may be used as proxies for each other, but the populations the two systems draw from are dif-
ferent, with the passive approach usually sampling from diseased animal groups, and the active
approach typically sampling from healthy animals, although it could be used for diseased ani-
mals as well. A passively acquired sample of diseased animals could be a partial subset of an
Fig 1. Observed ecological diversities of the swine S. Typhimurium var. 5- AMR profiles for all values
of the q parameter, including Species richness [SR], Shannon entropy [SE], Simpson diversity [SD],
Berger-Parker [BP] for passive surveillance (red) and active surveillance (black) isolates with
confidence intervals (dotted lines) for the passive surveillance sample generated by subsampling to
the size of the active surveillance sample.
doi:10.1371/journal.pone.0158515.g001
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active sample of healthy animals, provided some animals become healthy enough to be re-
introduced into the foodchain, but this is not necessarily, nor should it be assumed to be, the
case in a given group of animals.
In this analysis we demonstrate that for the prevalence of resistance to individual antimicro-
bials, the two systems were indeed indistinguishable, using a conservative cut-off. However,
when we came to compare the approaches and their ability to detect resistance phenotypes, we
demonstrate that passive surveillance using veterinary clinical diagnostic samples was more
effective at detecting rare AMR phenotypes of Salmonella than active surveillance of healthy
animals.
Starting with the individual resistances and examining the prevalence of resistance, a com-
monly examined measure when investigating AMR, we found no significant difference in the
prevalences of resistance to individual antimicrobials or in the overall percentage of resistance
between isolates obtained from passive and active surveillance. The evidence from previously
published work has been mixed: Johnson et al. [28] found generally no difference between clin-
ical (passive) and monitoring (active) isolates when the animal source of isolates was consid-
ered, but Poppe et al. [27] reported that clinical isolates were more likely to exhibit AMR than
isolates collected through targeted surveys. Investigations of other diseases and disease causing
agents, such as dengue [31], vancomycin-resistant enterococci [32], and invasive pneumococ-
cal disease [33], have shown that passive and active surveillance can result in different preva-
lence estimates.
However, considering resistance to individual antimicrobials rather than the resistance profile
ignores the co-selection of resistance that can occur through gene linkage, and can be misleading
if considered alone; using the entire resistance phenotype implicitly takes any such dependencies
Fig 2. Observed ecological diversities of the poultry S. Heidelberg AMR profiles for all values of the q
parameter, including Species richness [SR], Shannon entropy [SE], Simpson diversity [SD], Berger-
Parker [BP] for passive surveillance (red) and active surveillance (black) isolates with confidence
intervals (dotted lines) for the active surveillance sample generated by subsampling to the size of the
passive surveillance sample.
doi:10.1371/journal.pone.0158515.g002
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into account, which is why the phenotype was used as the main unit of analysis for the diversity
analyses. WhenMDR is considered, there was a significantly higher prevalence of MDR in the
passive surveillance isolates than in those collected through active surveillance. Furthermore,
examining diversity rather than prevalence provides a different perspective with which to com-
pare the two systems. Here we tested whether or not the observed numbers of phenotypes sup-
port the hypothesis that the passive and active approaches were sampling from the same
bacterial population, granted that the host populations differed in their state of wellness. Using
this statistical resampling approach to assess mixing of the sampled bacterial populations, we
demonstrated differences between our two examples. In the case of the poultry data, the number
of phenotypes detected by passive surveillance of animal clinical isolates was significantly higher
than expected, and the number detected by active surveillance of isolates from healthy animals
significantly lower than expected, suggesting here that the two approaches may not have been
sampling from the same population of phenotypes, or that some bias had occurred at the sam-
pling level for one, or both, of the surveillance methods. In contrast, in the swine data, the num-
bers of phenotypes detected by passive and active surveillance were as expected, although the
results were in the same direction as the poultry data. Whether this difference between livestock
species is due to differences in the pathogen, the host or sampling is not clear. There are well-
documented differences in the AMR patterns of different Salmonella serovars [5,27], and there
are inherent differences in the biology of the two animal species and the antimicrobial use, man-
agement and husbandry practices in each. Nevertheless, the poultry data alone demonstrate that
approaches that involve the entire phenotype rather than the individual resistance can yield
additional information and potentially lead to alternative conclusions.
Our findings when we considered only rare phenotypes were more encouraging. Regardless
of whether distinguishable or common microbial communities are being sampled, a key issue
for early detection is the ability to identify rare phenotypes—newly emergent resistance pat-
terns being rare by definition, although rare phenotypes are not necessarily emergent. For both
our datasets, passive surveillance of diseased animals was more successful. At low values of q,
the passive surveillance isolates had greater diversity than those acquired by active surveillance
for both swine and poultry, demonstrating more unique profiles. There are a number of possi-
ble biological explanations why this might be the case, including but not limited to bacterial
population, husbandry and antimicrobial exposure differences between healthy and clinically
ill hosts, as already discussed. Our findings are consistent with those of Afema et al. [34], who
examined Salmonella from clinical and non-clinical dairy cattle sources, and those of Perron
et al. [35], who examined S. Typhimurium DT104 isolates from clinically diseased and asymp-
tomatic pigs in a cross-sectional study, where both studies found greater diversity of resistance
phenotypes in clinical isolates.
The results of our analyses relate to these particular host/bacterium combinations in Can-
ada; similar assessments in other host species, bacteria, and countries would be useful to deter-
mine whether or not the observations made here are consistent in other settings. There are
other definitions of passive surveillance, and such surveillance systems in other countries may
include other types of sampling, such as repetitive sampling from commercial sources or sam-
ples collected for purposes other than AMR investigation, the influence of which would need
to be assessed. With respect to the poultry data, there may be isolates from breeding stock and
layers as well as broilers included in the passive surveillance sample, whereas the active surveil-
lance isolates were derived from broilers, and this may have led to differences in the two sur-
veillance samples. In addition, while isolates obtained from clinical cases are likely to be from
animals of all ages, there may be a higher proportion of isolates from younger animals, as
this age group tends to experience more illness from bacterial diseases [36,37]. In the active
surveillance sample, the majority of isolates were from animals of approximately the same age
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within each animal species, that at which the animals are typically sent to slaughter. There are
also several acknowledged biases inherent in passive surveillance [12–14], such as variation in
clinician submission behaviour; as there is no additional information to assess these biases in
our data, it cannot be identified if any of these biases were present. However, it is noteworthy
that many of these potential biases, such as multiple isolates submitted per individual, either
relate to cases where prevalence estimation, rather than diversity, is the objective, or relate to
heterogeneity of laboratory practice in serotyping, phage typing and susceptibility testing,
which was not an issue in these analyses.
The role of passive surveillance has been previously acknowledged in the detection of new
resistances [15,38], and there has been some discussion of how this might be improved
[15,38,39]. The conclusions from these previous studies suggest that key to the identification of
emerging resistances are accurate data, a mechanism for recognising unusual resistance pat-
terns, and the ability to discern unusual results whether as the result of laboratory error or a
genuinely new pattern.
There are important implications for public health: If novel resistance types can be identi-
fied and the epidemiological risks mitigated, then, with appropriate intervention, the efficacy
of antimicrobials might be preserved. Early detection is an important component of supporting
any prudent use policy, which must also be balanced with the need to provide antimicrobials to
animals or humans who require treatment. Phenotype or strain diversity is a component not
routinely considered in AMR surveillance systems, either in their design or in their interpreta-
tion but our findings suggest that their routine inclusion warrants further investigation.
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